Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Stephanie E. Combs & Jürgen Debus. (2013) Treatment with heavy charged particles: Systematic review of clinical data and current clinical (comparative) trials. Acta Oncologica 52:7, pages 1272-1286.
Read now
Read now
Articles from other publishers (31)
Gregory P. Botta, Tridu R. Huynh, Samantha R. Spierling‐Bagsic, Alexander Agelidis, Randolph Schaffer, Ray Lin & Darren Sigal. (2022)
Neoadjuvant chemotherapy and radiotherapy outcomes in
borderline‐resectable
and
locally‐advanced
pancreatic cancer patients
. Cancer Medicine 12:7, pages 7713-7723.
Crossref
Crossref
Nirav Thosani, Putao Cen, Julie Rowe, Sushovan Guha, Jennifer M. Bailey-Lundberg, Dimpal Bhakta, Prithvi Patil & Curtis J. Wray. (2022) Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for advanced pancreatic and periampullary adenocarcinoma. Scientific Reports 12:1.
Crossref
Crossref
Valeria Merz, Domenico Mangiameli, Camilla Zecchetto, Alberto Quinzii, Silvia Pietrobono, Carlo Messina, Simona Casalino, Marina Gaule, Camilla Pesoni, Pasquale Vitale, Chiara Trentin, Michela Frisinghelli, Orazio Caffo & Davide Melisi. (2022) Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer. Frontiers in Surgery 9.
Crossref
Crossref
Ali Zakaria, Bayan Al-Share, Jason B. Klapman & Aamir Dam. (2022) The Role of Endoscopic Ultrasonography in the Diagnosis and Staging of Pancreatic Cancer. Cancers 14:6, pages 1373.
Crossref
Crossref
Dunya Alfaraj, Rawan O AlOtaibi, Reema M Bamousa & Jana F Alzamami. (2022) Pathological Fracture as the Initial Presentation of Metastatic Pancreatic Cancer. Cureus.
Crossref
Crossref
Pablo Martí-Cruchaga, Javier A. Cienfuegos & Fernando Rotellar. (2022) Neoadjuvant treatment in localized and resectable cancer of the pancreas: a new therapeutic paradigm. Revista Española de Enfermedades Digestivas.
Crossref
Crossref
Riccardo De Robertis, Paola Capelli, Chiara Longo & Mirko D’Onofrio. 2022. Imaging and Pathology of Pancreatic Neoplasms. Imaging and Pathology of Pancreatic Neoplasms
99
139
.
Ahmad Hamad, Zachary J Brown, Aslam M Ejaz, Mary Dillhoff & Jordan M Cloyd. (2021) Neoadjuvant therapy for pancreatic ductal adenocarcinoma: Opportunities for personalized cancer care. World Journal of Gastroenterology 27:27, pages 4383-4394.
Crossref
Crossref
Alvaro Gregorio Morales Taboada, Pablo Lozano Lominchar, Lorena Martin Roman, Pilar García-Alfonso, Andres Jesús Muñoz Martin, Jose Antonio Blanco Rodriguez & Jose Manuel Asencio Pascual. (2021) Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades. Annals of Hepato-Biliary-Pancreatic Surgery 25:2, pages 179-191.
Crossref
Crossref
Qiancheng Hu, Dan Wang, Ye Chen, Xiaofen Li, Peng Cao & Dan Cao. (2019) Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma. Radiation Oncology 14:1.
Crossref
Crossref
L. G. Zhukova, K. S. Grechukhina, S. A. Smolin & B. I. Bammatov. (2019) The role of systemic therapy in localized pancreatic cancer (review). Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 24:3, pages 65-72.
Crossref
Crossref
Margaret A. TemperoMokenge P. MalafaE. Gabriela ChioreanBrian CzitoCourtney ScaifeAmol K. NarangChristos FountzilasBrian M. WolpinMahmoud Al-HawaryHoracio AsbunStephen W. BehrmanAl B. BensonEllen BinderDana B. CardinCharles ChaVincent ChungMary DillhoffEfrat DotanCristina R. FerroneGeorge FisherJeffrey HardacreWilliam G. HawkinsAndrew H. KoNoelle LoConteAndrew M. LowyCassadie MoravekEric K. NakakuraEileen M. O’ReillyJorge ObandoSushanth ReddySarah ThayerRobert A. Wolff, Jennifer L. BurnsGriselda Zuccarino-Catania. (2019) Guidelines Insights: Pancreatic Adenocarcinoma, Version 1.2019. Journal of the National Comprehensive Cancer Network 17:3, pages 202-210.
Crossref
Crossref
Chien-Ting Kao, Muhammad Aziz & Anup Kasi. (2018) Pathological complete response in pancreatic adenocarcinoma with FOLFIRINOX. BMJ Case Reports, pages bcr-2018-225621.
Crossref
Crossref
Shi Wen, Bohan Zhan, Jianghua Feng, Weize Hu, Xianchao Lin, Jianxi Bai & Heguang Huang. (2017) Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling. BMC Cancer 17:1.
Crossref
Crossref
Aleksandra Adamska, Alice Domenichini & Marco Falasca. (2017) Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies. International Journal of Molecular Sciences 18:7, pages 1338.
Crossref
Crossref
Sarunas Sliesoraitis & Thomas J. GeorgeJr.Jr.. 2016. Pancreatic Masses. Pancreatic Masses
251
270
.
Nicole E Lopez. (2014) Borderline resectable pancreatic cancer: Definitions and management. World Journal of Gastroenterology 20:31, pages 10740.
Crossref
Crossref
Stephanie E Combs, Daniel Habermehl, Meinhard Kieser, Constantin Dreher, Jens Werner, Renate Haselmann, Oliver J?kel, Dirk J?ger, Markus W B?chler & J?rgen Debus. (2013) Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial. BMC Cancer 13:1.
Crossref
Crossref
George Van BurenIIII, Ramesh K. Ramanathan, Alyssa M. Krasinskas, Ryan P. Smith, Gerard J. Abood, Nathan Bahary, Barry C. Lembersky, Yongli Shuai, Douglas M. Potter, David L Bartlett, Amer H. Zureikat, Herbert J. Zeh & A. James Moser. (2013) Phase II Study of Induction Fixed-Dose Rate Gemcitabine and Bevacizumab Followed by 30 Gy Radiotherapy as Preoperative Treatment for Potentially Resectable Pancreatic Adenocarcinoma. Annals of Surgical Oncology 20:12, pages 3787-3793.
Crossref
Crossref
An Tai, Zhiwen Liang, Beth Erickson & X. Allen Li. (2013) Management of Respiration-Induced Motion With 4-Dimensional Computed Tomography (4DCT) for Pancreas Irradiation. International Journal of Radiation Oncology*Biology*Physics 86:5, pages 908-913.
Crossref
Crossref
Hiroyuki Kato, Masanobu Usui, Shuji Isaji, Takukazu Nagakawa, Keita Wada, Michiaki Unno, Akimasa Nakao, Shuichi Miyakawa & Tetsuo Ohta. (2013) Clinical features and treatment outcome of borderline resectable pancreatic head/body cancer: a multi‐institutional survey by the Japanese Society of Pancreatic Surgery. Journal of Hepato-Biliary-Pancreatic Sciences 20:6, pages 601-610.
Crossref
Crossref
Jens Werner, Stephanie E. Combs, Christoph Springfeld, Werner Hartwig, Thilo Hackert & Markus W. Büchler. (2013) Advanced-stage pancreatic cancer: therapy options. Nature Reviews Clinical Oncology 10:6, pages 323-333.
Crossref
Crossref
Hidenori Takahashi, Hiroaki Ohigashi, Osamu Ishikawa, Kunihito Gotoh, Terumasa Yamada, Shigenori Nagata, Yasuhiko Tomita, Hidetoshi Eguchi, Yuichiro Doki & Masahiko Yano. (2012) Perineural Invasion and Lymph Node Involvement as Indicators of Surgical Outcome and Pattern of Recurrence in the Setting of Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable Pancreatic Cancer. Annals of Surgery 255:1, pages 95-102.
Crossref
Crossref
Tae Hyun Kim, Sung-Sik Han, Sang-Jae Park, Woo Jin Lee, Sang Myung Woo, Tae Yoo, Sung Ho Moon, Seong Hoon Kim, Eun Kyung Hong, Dae Yong Kim & Joong-Won Park. (2011) CA 19-9 Level as Indicator of Early Distant Metastasis and Therapeutic Selection in Resected Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics 81:5, pages e743-e748.
Crossref
Crossref
M. Mura Assifi, Xuyang Lu, Guido Eibl, Howard A. Reber, Gang Li & O. Joe Hines. (2011) Neoadjuvant therapy in pancreatic adenocarcinoma: A meta-analysis of phase II trials. Surgery 150:3, pages 466-473.
Crossref
Crossref
Hidenori Takahashi, Hisataka Ogawa, Hiroaki Ohigashi, Kunihito Gotoh, Terumasa Yamada, Masayuki Ohue, Isao Miyashiro, Shingo Noura, Kentaro Kishi, Masaaki Motoori, Tatsushi Shingai, Satoaki Nakamura, Kinji Nishiyama, Masahiko Yano & Osamu Ishikawa. (2011) Preoperative chemoradiation reduces the risk of pancreatic fistula after distal pancreatectomy for pancreatic adenocarcinoma. Surgery 150:3, pages 547-556.
Crossref
Crossref
Hidenori Takahashi, Hiroaki Ohigashi, Osamu Ishikawa, Hidetoshi Eguchi, Kunihito Gotoh, Terumasa Yamada, Akihiko Nakaizumi, Hiroyuki Uehara, Yasuhiko Tomita, Kinji Nishiyama & Masahiko Yano. (2010) Serum CA19–9 Alterations During Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable Invasive Ductal Carcinoma of the Pancreas as an Indicator for Therapeutic Selection and Survival. Annals of Surgery 251:3, pages 461-469.
Crossref
Crossref
Claudio Bassi, Matilde Bacchion & Giovanni Marchegiani. 2010. New Concepts in Diagnosis and Therapy of Pancreatic Adenocarcinoma. New Concepts in Diagnosis and Therapy of Pancreatic Adenocarcinoma
113
122
.
Y. TOUCHEFEU, M. LE RHUN, E. CORON, A. ALAMDARI, M. F. HEYMANN, J. F. MOSNIER, T. MATYSIAK & J. P. GALMICHE. (2009) Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of solid pancreatic masses: the impact on patient-management strategy. Alimentary Pharmacology & Therapeutics 30:10, pages 1070-1077.
Crossref
Crossref
Manuel Hidalgo, Albert Abad, Enrique Aranda, Luis Díez, Jaime Feliu, Carlos Gómez, Antonio Irigoyen, Rafael López, Fernando Rivera, Carmen Rubio, Javier Sastre, Josep Tabernero & Eduardo Díaz-Rubio. (2009) Consensus on the treatment of pancreatic cancer in Spain. Clinical and Translational Oncology 11:5, pages 290-301.
Crossref
Crossref
Gregory M. SpringettSarah E. Hoffe. (2008) Borderline Resectable Pancreatic Cancer: On the Edge of Survival. Cancer Control 15:4, pages 295-307.
Crossref
Crossref